Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

Add To Watchlist

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Time to get out?

View:

Post by XRRH2008 on Jun 23, 2017 10:04am

Time to get out?

Friend of mine also invetsed in COT thinks this will be 12 to 15 cents by next week. Thoughts?

222

Comment

Comment by DIYGuy on Jun 23, 2017 10:59am

It all depends on what the financing is done at. 12-15 gives a valuation of 18-22 million. I can't get out even I wanted to as there isn't much on the bid. Does anyone know if the trial was set up to allow a dose decline between cohort 3 (1.0mg/kg) and cohort 4 (1.7mg/kg). I would expect you do not want a MTD too weak as it may not have the efficacy required to move to phase 2 or the dose ...more

203

Comment

Cotinga Pharmaceuticals Inc